News

Autologous mononuclear cells showed substantial activity in patients with advanced heart failure — and even though the study ...
A team of researchers from the Keck School of Medicine of USC has developed an advanced tool for analyzing chimeric antigen ...
Scientists have the technology to grow humans in Petri dishes, but they say there are better uses for it: to combat aging.
But not all cord blood units are equal – the Nature Medicine study pinpointed key factors that drive NK cell potency. Units with fewer nucleated red blood cells and collection-to ...
In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical. At the 4th Cell Therapy Potency Assay Summit, we will unite analytical development ...
Announcing a new article publication for BIO Integration journal. Bladder cancer (BLCA) is one of the most common malignancies and the second most frequent urogenital tract tumor.
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael E Carazo Salas ...
The Conference Forum announced that the Immuno-Oncology 360º (IO360º) Summit honored Crystal Mackall, MD, FAAP, FAACR, Stanford University, with the IO360º Lifetime Achievement Award for her ...
The viral potency is normally measured by the quantification of hemagglutinin (HA), a type of glycoprotein embedded in the viral bilayer and on the virus's outer surface contained in the virosomes. In ...
CDR-Life today announced the presentation of data for its novel T cell engager (TCE) programs at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. The presentations ...